Tacrolimus

interleukin 2 ; Mus musculus







28 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34144106 The impact of locally-delivered tacrolimus-releasing microspheres and polyethylene glycol-based islet surface modification on xenogeneic islet survival. 2021 Aug 10 4
2 28522399 Anti-allergic and Profilaggrin (ProFLG)-mRNA expression modulatory effects of sacran. 2017 Dec 1
3 25333459 IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice. 2015 Jan 1
4 25770929 Nordihydroguiaretic acid attenuates skin tumorigenesis in Swiss albino mice with the condition of topical co-administration of an immunosuppressant. 2015 May 25 1
5 23390586 Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo. 2013 Feb 5 2
6 19627009 [Effect of FK506 and CSA on the cell survival of engrafted HSC and the level of IL-2 and IL-4 in leukemia mice]. 2009 May 2
7 19766187 Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice. 2009 Dec 1
8 18656798 Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development. 2008 Aug 1
9 15919519 Inhibition of MD-1 expression by immunosuppressants or antisense oligodeoxynucleotides on skin allograft survival in mice. 2005 May 2
10 11935154 Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. 2002 Feb 2
11 10798785 STAT 6 up-regulation by FK506 in the presence of interleukin-4. 2000 Apr 15 1
12 9566798 The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction. 1998 Apr 1
13 9605132 Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. 1998 Jun 1 1
14 9336339 FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. 1997 Oct 1
15 8617295 B7-1 synergizes with interleukin-12 in interleukin-2 receptor alpha expression by mouse T helper 1 clones. 1996 Feb 1
16 8986461 Mode of action of FK-506 on protective immunity to Hymenolepis nana in mice. 1996 Nov-Dec 4
17 7530743 The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells. 1995 Feb 15 1
18 7875200 Induction of interleukin-2 transcription by the hamster polyomavirus middle T antigen: a role for Fyn in T cell signal transduction. 1995 Feb 1
19 7682200 Regulation of liver regeneration by interleukin-2 and its inhibitors: cyclosporine A and FK 506. 1993 Feb 3
20 7692640 A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells. 1993 Oct 2
21 1371158 Cyclosporine and FK506 inhibition of murine mast cell cytokine production. 1992 Feb 1
22 1384815 The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines. 1992 Sep 1
23 1688572 Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. 1990 Jan 1 2
24 1689226 Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal. 1990 Jan 1
25 1689353 The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. 1990 Feb 15 2
26 1696410 Effect of FK506 treatment on allocytolytic T lymphocyte induction in vivo: differential effects of FK506 on L3T4+ and Ly2+ T cells. 1990 Aug 1
27 1702375 Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion. 1990 Dec 1
28 2442255 Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. 1987 Sep 15 2